Drugs / Plain Lactobacillus reuteri
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07366229 | Dec 2025 → Mar 2026 overdue | acne | Shenzhen People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plain Lactobacillus reuteri | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07366229 ↗ |
| Modality | Other / unclassified | “a common probiotic-Lactobacillus reuteri” NCT07366229 ↗ |
| Route | Topical | “should be applied topically to acne lesions” NCT07366229 ↗ |